Point72 Asset
View Older Stories View More Recent Stories
-
Point72 increases Lionsgate Studios stake to 14.7 million shares
-
Form SCHEDULE 13G Lionsgate Studios Corp. Filed by: Point72 Asset Management, L.P.
-
Cohen Veterans Network Celebrates 5th Anniversary of the Cohen Clinic in Mililani and Expands Mental Health Services for Hawaii's Veteran and Military Communities
-
Form SCHEDULE 13G TENAX THERAPEUTICS, INC. Filed by: Point72 Asset Management, L.P.
-
MGM Resorts Stock Price Responds to Shock NYC Project Withdrawal
-
ETHIS Launched during San Francisco Tech Week at Homebrew Computer Club
-
Republican donor lobbies in favor of anti-Western Georgian Dream
-
Wounded Warrior Project Powers Nationwide Network of Veteran Care with New Year of Funding
-
Form SCHEDULE 13G C4 Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G WOLFSPEED, INC. Filed by: Point72 Asset Management, L.P.
-
VSiN, The Sports Betting Network, Expands Podcast Network to Meet the Varied Interests of Today’s Sports Fans
-
Form SCHEDULE 13G PALISADE BIO, INC. Filed by: Point72 Asset Management, L.P.
-
Cohen Veterans Network Announces Support from American Airlines
-
Buyers Edge Platform Strengthens Club Market Leadership with NGCRA Acquisition
-
Forward Air Raises $526,000 for Veterans at 2025 Drive for Hope Golf Tournament
-
Cohen Veterans Network (CVN) and Blue Star Families (BSF) Announce National Partnership to Enhance Support for Military and Veteran Families
-
Form SCHEDULE 13G Aptevo Therapeutics Inc. Filed by: Point72 Asset Management, L.P.
-
ADHC Announces First Digital Asset Treasury Purchase With Acquisition of Solana Based OTCfi Tokens
-
Form SCHEDULE 13G Dianthus Therapeutics, Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G KALA BIO, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G FG Nexus Inc. Filed by: Point72 Asset Management, L.P.
-
Sphinx launches with $9.5M to redefine how AI works with data
-
Cohen Veterans Network Unveils "Have Her Six" Campaign to Combat Suicide Crisis Among Military Women
-
Form SCHEDULE 13G PLIANT THERAPEUTICS, Filed by: Point72 Asset Management, L.P.
-
Goldcrest Farm Trust Closes Third Fund with $300 Million in Institutional Commitments
-
Form N-PX Point72 Asset Management For: Jun 30
-
Form SCHEDULE 13G WOLVERINE WORLD WIDE Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G Design Therapeutics, Filed by: Point72 Asset Management, L.P.
-
MAKE ME COMMISSIONER: I KNOW WHAT'S WRONG WITH BASEBALL AND HOW TO FIX IT
-
FanDuel Sports Network and VSiN Partner to Bring Sports Betting Content to Fans Nationwide
-
50T Welcomes Michael Scott as Senior Partner, Strengthening Leadership Team with Proven Credit Markets Expertise
-
Form SCHEDULE 13G Invivyd, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G iBio, Inc. Filed by: Point72 Asset Management, L.P.
-
VSiN Launches Fall Programming Lineup, Giving Fans More of Their Favorite Sports Betting Shows and Hosts
-
Form SCHEDULE 13G Kodiak Sciences Inc. Filed by: Point72 Asset Management, L.P.
-
Cohen Veterans Network Tackles Rising Suicide Rate Among Military-Affiliated Women with New Toolkit for Clinicians
-
Point72 Asset Management files schedule 13G reporting 4.0% stake in ALT5 Sigma
-
Form SCHEDULE 13G Syndax Pharmaceuticals Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G ALT5 Sigma Corp Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Syndax Pharmaceuticals Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A VNET Group, Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Dianthus Therapeutics, Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Shoals Technologies Grou Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A CytomX Therapeutics, Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Cidara Therapeutics, Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Lumentum Holdings Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A CYBIN INC. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Regulus Therapeutics Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Sagimet Biosciences Inc. Filed by: Point72 Asset Management, L.P.
-
Form SCHEDULE 13G/A Praxis Precision Medicin Filed by: Point72 Asset Management, L.P.

